期刊文献+

曲伏前列素的合成 被引量:1

Synthesis of Travoprost
原文传递
导出
摘要 以苯甲酰Corey内酯(1)为起始物料,经过2,2,6,6-四甲基哌啶氧化物(TEMPO)/次氯酸钠选择性氧化、Wittig-Hornor反应、手性还原、脱苯甲酰基、三乙基氯硅烷保护羟基、内酯还原、Wittig反应、成酯、羟基保护与脱保护共10步反应,得到最终产物曲伏前列素(13),总收率15.3%。终产物经^(1)H NMR、^(13)C NMR和MS进行结构确证。该合成路线中使用乙醇/正己烷打浆法、甲基叔丁基醚重结晶和硅胶柱色谱等方法对各个中间体的分离纯化操作进行简化,原料易得、条件温和且可控,为国内曲伏前列素类仿制药的工业生产提供了参考。 Travoprost(13)was obtained with benzoyl Corey lactone(1)as the starting material in a ten-step synthetic route,which consisted of selective oxidation in the presence of 2,2,6,6-tetramethyl-1-piperidinyloxy(TEMPO)/sodium hypochlorite,Wittig-Hornor reaction,chiral reduction,debenzoylation,triethylchlorosilane protection of hydroxyl,lactone reduction,Wittig reaction,ester formation,hydroxyl protection and deprotection,with the total yield of 15.3%.The structure of the final product was confirmed by ^(1)H NMR,^(13)C NMR and MS.In this paper,the separation and purification processes of various intermediates were simplified by pulping with ethanol/n-hexane,recrystallization by methyl tert-butyl ether and separation by silica gel column chromatography.By the way,the synthetic route had the advantages of availability of raw materials,and mild and controllable reaction conditions,which could provide some references for the industrial production of travoprost generic drugs.
作者 陈祥伟 苏专专 黄文战 甘春丽 CHEN Xiangwei;SU Zhuanzhuan;HUANG Wenzhan;GAN Chuni(Dept.of Pharmaceutical Chemistry and Natural Pharmaceutical Chemistry,College of Pharmacy,Harbin Medical University,Harbin 150081)
出处 《中国医药工业杂志》 EI CAS CSCD 2024年第1期42-47,95,共7页 Chinese Journal of Pharmaceuticals
基金 黑龙江省高等教育本科教育教学改革研究重点委托项目(SJGZ20220079) 黑龙江省博士后科研启动金(21042220041) 哈尔滨医科大学药学院优秀青年人才基金(2019-YQ-04)。
关键词 曲伏前列素 苯甲酰Corey内酯 中间体 合成 WITTIG反应 travoprost benzoyl Corey lactone intermediate synthesis Wittig reaction
  • 相关文献

参考文献1

二级参考文献19

  • 1廖琳,唐瑛.前列腺素与临床[J].临床医学,1996,16(5):51-53. 被引量:21
  • 2Al - Jazzaf AM, DeSantis L, Netland PA. Travoprost: a potent ocular hypotensive agent [J ]. Drugs Today (Barc), 2003,39(1) : 61.
  • 3Bito LZ, Camras CB, Gum GG, et al. The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals[J].Prog Clin Biol Res, 1989,312: 349.
  • 4Gabelt BT, Kaufman PL. Prostaglandin F2 alpha increases uveosclera outflow in the cynomolgus monkey [J ]. Exp Eye Res, 1989,49(3) : 389.
  • 5Stjernschantz JW. From PGF (2alpha) -isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture[J ]. Invest Ophthalmol Vis Sci ,2001,42(6) : 1 134.
  • 6Hellberg MR, Sallee VL, McLaughlin MA, et al. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist[J].J Ocul Pharmacol Ther, 2001,17(5): 421.
  • 7Whitson JT. Travoprost - a new prostaglandin analogue for the trement of glaucoma[J].Expert Opin Pharmacother, 2002,3(7): 965.
  • 8McCue BA, Cason MM, Curtis MA, et al. Determination of travoprost and travoprost free acid in human plasma by electrospray HPLC/MS/MS[J].J Pharrn Biomed Anal, 2002,28(2) : 199.
  • 9Sharif NA, Davis TL, Williams GW. [3H] AL-5848 ( [3H] 9beta - (+) - Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor[J ] .J Pharm Pharmacol, 1999, 51(6) : 685.
  • 10Netland PA, Landry T, Sullivan EK, et al. Travoprost compared with latanoprost and timolol in patients with open - angle glaucoma or ocular hypertension[J]. Am J Ophthalmol,2001,132( 4) :472.

共引文献10

同被引文献21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部